| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912390 | Lung Cancer | 2005 | 7 Pages |
Abstract
Conclusions: Selected patients with an early N status may be appropriate candidates for aggressive multimodality treatment including surgery, in order to provide a long-term survival for stage IV NSCLC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tatsuro Okamoto, Riichiroh Maruyama, Fumihiro Shoji, Hiroshi Asoh, Jiro Ikeda, Tetsuya Miyamoto, Tomomi Nakamura, Tetsuro Miyake, Yukito Ichinose,